People

Kylee Haller

synapticure.com

Kylee Haller — Synapticure publishes the following professional biography and affiliation: is a speech-language pathologist specializing in neurodegenerative diseases, with extensive experience treating ALS, Parkinson's, and other neurologic conditions. She is dedicated to improving patient quality of life through personalized assessment, therapy, and assistive technology integration. VA Pittsburgh Healthcare System (Speech-Language Pathology) Graduate - University of Minnesota (Speech-Language Pathology) Undergraduate - University of Minnesota (Speech-Language-Hearing Sciences & Neuroscience) American Speech-Language-Hearing Association (ASHA) Certificate of Clinical Competence in Speech-Language Pathology (ASHA) Huntington’s Study Group (HSG) Rehab Committee, Member Kylee Haller is a speech-language pathologist with advanced training in neurodegenerative diseases. She completed her undergraduate and graduate degrees in speech-language pathology at the University of Minnesota. During her fellowship at the VA Pittsburgh Healthcare System, Kylee gained specialized experience treating a range of neurologic conditions in the veteran population, with a focus on ALS and Parkinson's disease through the PADRECC program. Prior to joining Synapticure, Kylee served as the sole speech-language pathologist at the Penn Medicine Movement Disorders Clinic, where she worked with multidisciplinary teams to treat patients with ALS, Parkinson’s disease, atypical parkinsonism, Huntington’s disease, and ataxia. She also collaborated closely with the Penn Memory and FTD Center, further refining her expertise in cognitive and motor disorders. Kylee is dedicated to providing personalized assessment and treatment for speech, language, cognition, swallowing, and the use of alternative and augmentative communication (AAC) devices. With a strong focus on functional outcomes, she is committed to improving her patient's quality of life through innovative therapy and the integration of assistive technologies. Invited Presentations ‍ - “Communication with a Tracheostomy – The Role of Speech-Language Pathology”, April 2022, PEEPS Talking PAP Conference (International – Virtual) - “Evaluation of cognitive-communication deficits following treatment of primary brain tumors”, October 2017, Mayo Clinic Radiation Oncology Grand Rounds (National – Rochester, MN) ‍ Presentations at National Meetings ‍ - “Cognitive-linguistic deficits following treatment of brain tumors: Results of a prospective pilot study”, October 2018, American Society of Radiation Oncology, San Antonio, TX. ‍ American Speech-Language-Hearing Association (ASHA) Certificate of Clinical Competence in Speech-Language Pathology (ASHA) Huntington’s Study Group (HSG) Rehab Committee, Member Current directory role is Speech-Language Pathologist.